Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients

被引:110
作者
Lanchou, J [1 ]
Corbel, M
Tanguy, M
Germain, N
Boichot, E
Theret, N
Clement, B
Lagente, V
Malledant, Y
机构
[1] Univ Rennes, INSERM U456, Rennes, France
[2] CHU Rennes, Hop Pontchaillou, Serv Reanimat Chirurg, Rennes, France
关键词
matrix metalloproteinases; tissue inhibitor of matrix metalloproteinases; acute respiratory distress syndrome; acute lung injury;
D O I
10.1097/01.CCM.0000048626.02184.F8
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Matrix metalloproteinases (MMPs) are known to be involved in degradation of extracellular matrix. We aimed to assess the role of MMPs and their natural inhibitors (TIMPs) in the genesis and the evolution of acute respiratory distress syndrome (ARDS). Design: Prospective, clinical study. Setting: Intensive care unit of a university hospital. Patients: Twenty-one patients were assigned to three different groups: Group 1 patients developed ARDS that rapidly resolved in <4 days; Group 2 patients developed ARDS lasting >8 days; Group 3 (control group) patients had clinical criteria for hospital-acquired pneumonia without ARDS. Intervention: Bronchoalveolar lavages were performed on day 0 of the onset of ARDS and on days 4, 8, and 12 for unresolving ARDS. For group 3, the bronchoalveolar lavages were performed on day 0 of the pneumonia. On these bronchoalveolar lavage fluids, we measured the amount of MMP-9 and -2 and their inhibitors TIMP-1 and -2. Measurements and Main Results: The amount of MMP-9 measured by enzyme-linked immunosorbent assay was significantly lower in the bronchoalveolar lavages from patients with ARDS (group 1 and group 2) compared with the control group (p < .01) throughout the study. The ratio MMP-9/TIMP-1 was also significantly smaller and was less than one in the two ARDS groups (p < .05) compared with the control group (group 3), where this ratio was greater than one. In the second bronchoalveolar lavages, this ratio was greater than one only in the ARDS group that rapidly resolved (group 1), whereas it stayed less than one when the ARDS was lasting (group 2). Concerning the quantity of MMP-2 and the ratio MMP-2/TIMP-2, there was no statistical difference between the three groups throughout the study. Using zymography, there was no significant difference in the amounts of active and latent MMP-9 between the three groups. Moreover, no significant difference in the quantity of latent and active MMP-2 in the three groups was noted. Conclusion: These results suggest that the MMP-9 level and MMP-9/TIMP-1 ratio play a role in the pathogenesis of ARDS and, namely, the imbalance between MMP-9 and TIMP-1 would participate in airway remodeling leading to either short- or long-course ARDS. The ratio MMP-9/TIMP-1 could be a predictive factor of the ARDS evolution.
引用
收藏
页码:536 / 542
页数:7
相关论文
共 32 条
[1]  
[Anonymous], AM J RESP CRIT CARE
[2]  
Bakowska J, 1998, J PATHOL, V185, P319, DOI 10.1002/(SICI)1096-9896(199807)185:3<319::AID-PATH114>3.0.CO
[3]  
2-L
[4]   THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
COCHIN, B ;
LANKEN, PN ;
LEEPER, KV ;
MARINI, J ;
MURRAY, JF ;
OPPENHEIMER, L ;
PESENTI, A ;
REID, L ;
RINALDO, J ;
VILLAR, J ;
VANASBECK, BS ;
DHAINAUT, JF ;
MANCEBO, J ;
MATTHAY, M ;
MEYRICK, B ;
PAYEN, D ;
PERRET, C ;
FOWLER, AA ;
SCHALLER, MD ;
HUDSON, LD ;
HYERS, T ;
KNAUS, W ;
MATTHAY, R ;
PINSKY, M ;
BONE, RC ;
BOSKEN, C ;
JOHANSON, WG ;
LEWANDOWSKI, K ;
REPINE, J ;
RODRIGUEZROISIN, R ;
ROUSSOS, C ;
ANTONELLI, MA ;
BELOUCIF, S ;
BIHARI, D ;
BURCHARDI, H ;
LEMAIRE, F ;
MONTRAVERS, P ;
PETTY, TL ;
ROBOTHAM, J ;
ZAPOL, W .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :818-824
[5]   PATHOGENESIS OF FIBROSIS IN ACUTE LUNG INJURY [J].
BITTERMAN, PB .
AMERICAN JOURNAL OF MEDICINE, 1992, 92 :S39-S43
[6]   Early detection of type III procollagen peptide in acute lung injury - Pathogenetic and prognostic significance [J].
Chesnutt, AN ;
Matthay, MA ;
Tibayan, FA ;
Clark, JG .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 156 (03) :840-845
[7]   TYPE-III PROCOLLAGEN PEPTIDE IN THE ADULT-RESPIRATORY-DISTRESS-SYNDROME - ASSOCIATION OF INCREASED PEPTIDE LEVELS IN BRONCHOALVEOLAR LAVAGE FLUID WITH INCREASED RISK FOR DEATH [J].
CLARK, JG ;
MILBERG, JA ;
STEINBERG, KP ;
HUDSON, LD .
ANNALS OF INTERNAL MEDICINE, 1995, 122 (01) :17-23
[8]  
Cuvelier A, 1997, REV MAL RESPIR, V14, P1
[9]   IMBALANCE BETWEEN 95 KDA TYPE-IV COLLAGENASE AND TISSUE INHIBITOR OF METALLOPROTEINASES IN SPUTUM OF PATIENTS WITH CYSTIC-FIBROSIS [J].
DELACOURT, C ;
LEBOURGEOIS, M ;
DORTHO, MP ;
DOIT, C ;
SCHEINMANN, P ;
NAVARRO, J ;
HARF, A ;
HARTMANN, DJ ;
LAFUMA, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (02) :765-774
[10]   Gelatinases in epithelial lining fluid of patients with adult respiratory distress syndrome [J].
Delclaux, C ;
dOrtho, MP ;
Delacourt, C ;
Lebargy, F ;
BrunBuisson, C ;
Brochard, L ;
Lemaire, F ;
Lafuma, C ;
Harf, A .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1997, 272 (03) :L442-L451